ArticleNanomaterials (Basel, Switzerland)2026
Dose-Response Relationships for Lung Tumor and Pleural Mesothelioma Induction by Repetitive Intratracheal Instillation of a Multiwalled Carbon Nanotube, MWCNT-7, in Rats: Comparison with Inhalation Carcinogenicity Based on Lung Burden.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
The multiwalled carbon nanotube, MWCNT-7, is carcinogenic to rat lungs when inhaled over the course of 2 years, but does not induce pleural mesothelioma. In contrast, intratracheal instillation of MWCNT-7 causes both lung tumors and pleural mesotheliomas. To explore the possibility of the use of the intratracheal instillation technique in risk characterization, we administered this widely used reference material using instillation to male F344 rats at doses of 0.0175, 0.07, 0.28, or 0.42 mg/kg once per week for 13 weeks, followed by an observation period of 91 weeks and compared the dose-response toxicological data with the 2-year inhalation study. Lung tumors and pleural mesotheliomas were induced in a dose-dependent manner (the 0.42 mg/kg group was excluded from analysis of lung tumor formation). The lung burden of MWCNT-7 at week 13 was dose-dependent: 0.0302, 0.191, 0.98, and 1.369 mg/lung in the 0.0175, 0.07, 0.28, and 0.42 mg/kg groups, respectively. The number of fibers in the pleural lavage fluid was also dose-dependent. The no-observed-adverse-effect-level (NOAEL) of MWCNT-7's carcinogenicity was 0.0302 mg/lung based on no significant lung tumor induction and no mesothelioma induction in the 0.0175 mg/kg group. When compared based on lung burden, the dose-response relationship and NOAEL of lung tumor induction resembled those in the 2-year inhalation study, offering the possibility of the application of this protocol for risk characterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.